Home » Topics » BioWorld Science

BioWorld Science
RSS

Ovid Therapeutics reports topline data from STARS study in Angelman syndrome

Aug. 7, 2018

First patient treated in phase I of HPN-424 in metastatic castration-resistant prostate cancer

Aug. 7, 2018

Researchers discover potent and selective histone deacetylase 11 inhibitors

Aug. 7, 2018

MediciNova, University of Cambridge to study ibudilast in degenerative cervical myelopathy

Aug. 7, 2018

Final results from PROPEL study support further clinical development of PTG-100 in UC

Aug. 7, 2018

Almac, Elasmogen and Innovate UK to develop VNAR-based oncology platform

Aug. 7, 2018

Upregulation of transgelin-2 by KRAS gene mutation contributes to pancreatic cancer development

Aug. 7, 2018

Hypermethylation variant silences BRCA1 gene

Aug. 7, 2018

miRNA-126 and miRNA-223 found significantly increased in cardiac sarcoidosis

Aug. 7, 2018

RNA delivery improves CF symptoms

Aug. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...